Akemi Tsutsui

3.5k total citations
27 papers, 574 citations indexed

About

Akemi Tsutsui is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Akemi Tsutsui has authored 27 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 14 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Akemi Tsutsui's work include Liver Disease Diagnosis and Treatment (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Akemi Tsutsui is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Akemi Tsutsui collaborates with scholars based in Japan. Akemi Tsutsui's co-authors include Yasuni Nakanuma, Tsuguhito Ota, Naoto Nagata, Yinhua Ni, Shuichi Kaneko, Fen Zhuge, Mayumi Nagashimada, Koichi Takaguchi, Kenichi Harada and Hiroshi Shibata and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Akemi Tsutsui

26 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akemi Tsutsui Japan 12 239 213 125 121 81 27 574
Tomohiko Ohashi Japan 14 314 1.3× 152 0.7× 94 0.8× 159 1.3× 13 0.2× 38 612
Theerut Luangmonkong Thailand 12 235 1.0× 225 1.1× 223 1.8× 98 0.8× 9 0.1× 17 643
Jesús García‐Bañuelos Mexico 14 175 0.7× 106 0.5× 157 1.3× 70 0.6× 11 0.1× 28 544
Kwangsik Chun South Korea 9 161 0.7× 90 0.4× 106 0.8× 123 1.0× 10 0.1× 18 478
H Moriwaki Japan 10 331 1.4× 290 1.4× 187 1.5× 68 0.6× 12 0.1× 22 664
Mingliang Cheng China 11 184 0.8× 94 0.4× 197 1.6× 32 0.3× 13 0.2× 19 482
B Tuchweber Canada 13 185 0.8× 245 1.2× 135 1.1× 180 1.5× 22 0.3× 42 612
Tetsuya Toyama Japan 10 323 1.4× 243 1.1× 174 1.4× 51 0.4× 8 0.1× 13 567
Vladimir J. Lozanovski Germany 14 81 0.3× 158 0.7× 168 1.3× 213 1.8× 17 0.2× 24 481
Mingming Meng China 9 267 1.1× 160 0.8× 253 2.0× 91 0.8× 7 0.1× 22 695

Countries citing papers authored by Akemi Tsutsui

Since Specialization
Citations

This map shows the geographic impact of Akemi Tsutsui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akemi Tsutsui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akemi Tsutsui more than expected).

Fields of papers citing papers by Akemi Tsutsui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akemi Tsutsui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akemi Tsutsui. The network helps show where Akemi Tsutsui may publish in the future.

Co-authorship network of co-authors of Akemi Tsutsui

This figure shows the co-authorship network connecting the top 25 collaborators of Akemi Tsutsui. A scholar is included among the top collaborators of Akemi Tsutsui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akemi Tsutsui. Akemi Tsutsui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Atsushi, Kenji Notohara, Maki Tobari, et al.. (2025). A clinicopathological study of IgG4-related autoimmune hepatitis and IgG4-hepatopathy. Journal of Gastroenterology. 60(5). 632–640.
2.
Tanaka, Atsushi, Keiji Tsuji, Yasuyuki Komiyama, et al.. (2024). RECAM‐J 2023—Validation and development of the Japanese version of RECAM for the diagnosis of drug‐induced liver injury. Hepatology Research. 54(6). 503–512. 7 indexed citations
3.
4.
Kariyama, Kazuya, Kazuhiro Nouso, Atsushi Hiraoka, et al.. (2023). Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective study. SHILAP Revista de lepidopterología. 24(1). 71–80. 1 indexed citations
5.
Minamikawa, Takeo, Eiji Hase, Mayuko Ichimura‐Shimizu, et al.. (2022). Assessment of Ultra-Early-Stage Liver Fibrosis in Human Non-Alcoholic Fatty Liver Disease by Second-Harmonic Generation Microscopy. International Journal of Molecular Sciences. 23(6). 3357–3357. 4 indexed citations
6.
Morishita, Asahiro, Kyoko Oura, Kei Takuma, et al.. (2022). Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study. Hepatology International. 17(3). 606–614. 23 indexed citations
8.
Kariyama, Kazuya, Kazuhiro Nouso, Atsushi Hiraoka, et al.. (2020). EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis. Liver Cancer. 9(6). 734–743. 36 indexed citations
9.
Takaguchi, Koichi, Akemi Tsutsui, Tomonori Senoh, et al.. (2019). Effects of dapagliflozin in type 2 diabetes patients with fatty liver. 2(1). 1 indexed citations
10.
Kariyama, Kazuya, Kazuhiro Nouso, Hidenori Toyoda, et al.. (2019). Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies. Liver Cancer. 9(1). 41–49. 31 indexed citations
11.
Hiraoka, Atsushi, Takashi Kumada, Kazuya Kariyama, et al.. (2018). Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis. Hepatology Research. 49(1). 111–117. 57 indexed citations
12.
Tsutsui, Akemi, Kenichi Harada, Koichi Tsuneyama, et al.. (2017). Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury. Digestive Diseases. 35(6). 506–514. 12 indexed citations
13.
Ni, Yinhua, Mayumi Nagashimada, Fen Zhuge, et al.. (2015). Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E. Scientific Reports. 5(1). 17192–17192. 212 indexed citations
14.
Tsutsui, Akemi, Yasuni Nakanuma, Kouichi Takaguchi, et al.. (2015). Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug‐Induced Liver Injury. Mediators of Inflammation. 2015(1). 913793–913793. 8 indexed citations
15.
Tsutsui, Akemi, Yoshimi Bando, Yasunori Sato, et al.. (2014). Biliary adenofibroma with ominous features of imminent malignant changes. Clinical Journal of Gastroenterology. 7(5). 441–448. 19 indexed citations
16.
Tsutsui, Akemi, et al.. (2005). Three‐dimensional reconstruction of endosonographic images of gastric lesions: Preliminary experience. Journal of Clinical Ultrasound. 33(3). 112–118. 8 indexed citations
17.
Tamaki, Katsuyoshi, Ichiro Shimizu, Hiroshi Inoue, et al.. (2004). Influence of large intrahepatic blood vessels on the gross and histological characteristics of lesions produced by radiofrequency ablation in a pig liver model. Liver International. 24(6). 696–701. 21 indexed citations
18.
Okamura, Seisuke, Yoshiaki Kusaka, Akemi Tsutsui, et al.. (2001). Quantitative Analysis of Red Color Sign in the Endoscopic Evaluation of Esophageal Varices. Endoscopy. 33(9). 747–753. 6 indexed citations
19.
Muguruma, Naoki, Seisuke Okamura, Masahiro Sogabe, et al.. (1998). Usefulness and Limitations of Endoscopic Ultrasonography in Diagnosis of Adenomyomatosis of the Gallbladder. Digestive Endoscopy. 10(3). 199–204. 1 indexed citations
20.
Ito, Susumu, Naoki Muguruma, Akemi Tsutsui, et al.. (1997). Development of an Imaging System Using Fluorescent Labeling Substances Excited by Infrared Rays. Digestive Endoscopy. 9(4). 278–282. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026